WO2018058720A1 - 一种建立血液电磁仿真模型的方法及装置 - Google Patents

一种建立血液电磁仿真模型的方法及装置 Download PDF

Info

Publication number
WO2018058720A1
WO2018058720A1 PCT/CN2016/103033 CN2016103033W WO2018058720A1 WO 2018058720 A1 WO2018058720 A1 WO 2018058720A1 CN 2016103033 W CN2016103033 W CN 2016103033W WO 2018058720 A1 WO2018058720 A1 WO 2018058720A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
simulation model
electromagnetic simulation
layer
lipid
Prior art date
Application number
PCT/CN2016/103033
Other languages
English (en)
French (fr)
Inventor
李景振
聂泽东
刘宇航
Original Assignee
深圳先进技术研究院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳先进技术研究院 filed Critical 深圳先进技术研究院
Publication of WO2018058720A1 publication Critical patent/WO2018058720A1/zh

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00Computer-aided design [CAD]
    • G06F30/20Design optimisation, verification or simulation

Definitions

  • the invention relates to the technical field of blood lipid detection, in particular to a method and a device for establishing a blood electromagnetic simulation model.
  • Blood lipids are a general term for neutral fats (triglycerides and cholesterol) and lipids (phospholipids, glycolipids, sterols, and steroids) in the blood, and are widely found in humans. They are essential for the metabolism of living cells. Patients with dyslipidemia are often associated with a variety of cardiovascular risk factors, and may even lead to diseases that seriously endanger human health, such as atherosclerosis, coronary heart disease, and pancreatitis. In order to improve people's healthy living standards, it is very important to test blood lipids.
  • the non-invasive blood lipid detection method is a method for obtaining the blood lipid concentration of a patient by using the reflection and transmission of electromagnetic waves, so that it is not necessary to collect the blood of the patient, and has the advantages of being non-invasive, simple, and quick.
  • Establishing a blood lipid test model is a prerequisite for studying non-invasive blood lipid detection technology.
  • researchers mainly use experimental statistical methods to model blood lipids, that is, through experimental animals to study the changes of blood lipids under different feeding methods, thus establishing a medical model such as hyperlipidemia.
  • CN103299950A discloses a method for establishing a model of cynomolgus monkey hyperlipemia and atherosclerosis, which is mainly to feed a cynomolgus monkey with a high-fat diet and to complete hyperlipidemia according to changes in biochemical indicators of cynomolgus monkeys. The establishment of the model.
  • Another Chinese patent CN102907357A discloses a method for constructing a zebrafish hyperlipidemia model by using yolk powder to feed zebrafish, chemically staining or fluorescent staining of zebrafish, and obtaining related images, images/microplates. Analysis and statistics were carried out to finally establish a model of hyperlipidemia in zebrafish.
  • the present invention provides a method and apparatus for establishing a blood electromagnetic simulation model, which aims to solve at least to some extent one of the above technical problems in the prior art.
  • the present invention provides the following technical solutions:
  • a method of establishing a blood electromagnetic simulation model comprising:
  • Step a establishing a blood electromagnetic simulation model
  • Step b calculating the number of blood lipid particles in the blood electromagnetic simulation model according to the concentration of blood lipids and the volume of blood in the blood electromagnetic simulation model;
  • Step c According to the calculation result, the blood lipid particles are randomly distributed in the blood electromagnetic simulation model, and by controlling the number of blood lipid particles, a blood electromagnetic simulation model with variable blood lipid concentration is established.
  • the technical solution adopted by the embodiment of the present invention further includes: before the step a, further comprising: determining an overall structure of the blood electromagnetic simulation model; the overall structure of the blood electromagnetic simulation model is a cylinder, and the blood electromagnetic simulation model includes a blood vessel layer
  • the blood layer and the blood lipid particle layer wherein the blood vessel layer, the blood layer and the blood lipid particle layer are distributed at the outermost layer, the blood vessel layer is at the outermost layer, the blood vessel layer has a length h, the blood vessel layer has an inner diameter d, and the outer diameter is D.
  • the technical solution adopted by the embodiment of the present invention further includes: in the step b, the calculation formula of the number of blood lipid particles in the blood electromagnetic simulation model is:
  • n is the number of blood lipid particles
  • N is the number of neutral fat molecules and lipid molecules
  • is the blood lipid concentration
  • V is the blood volume
  • M ⁇ ⁇ V / 1000
  • N A 6.02 ⁇ 10 23
  • V 1000 ⁇ ⁇ (d / 2) 2 ⁇ h.
  • the technical solution adopted by the embodiment of the present invention further includes: in the step c, the establishing a blood electromagnetic simulation model with variable blood lipid concentration specifically includes:
  • Step c1 generating n random numbers ⁇ 1 , ⁇ 1 , ⁇ 1 , ..., ⁇ n ⁇ uniformly distributed between (-1, 1 );
  • Step c2 According to the central limit theorem of probability theory, generate a random value obeying the normal distribution N( ⁇ , ⁇ ), and the formula for generating a random value is:
  • ⁇ i is a uniformly distributed random number
  • is the expected value of a normal distribution random number
  • is the mean square error of a normal distribution random number
  • n is a uniformly distributed random number required to generate a normal distribution random number.
  • Step c3 Determine the position of each blood lipid particle in the blood electromagnetic simulation model according to the above formula for generating a random value, and establish a blood electromagnetic simulation model with variable blood lipid concentration.
  • the technical solution adopted by the embodiment of the present invention further includes: after the step c, the method further comprises: fitting the electromagnetic parameters of the blood layer and the blood vessel layer in the blood electromagnetic simulation model by using the triple debye-drude model, and introducing the fitting result into the blood.
  • the blood electromagnetic simulation model is numerically calculated.
  • an apparatus for establishing a blood electromagnetic simulation model comprising:
  • the first model building module is used to establish a blood electromagnetic simulation model
  • Blood lipid particle number calculation module for calculating the number of blood lipid particles in the blood electromagnetic simulation model according to the concentration of blood lipids and the volume of blood in the blood electromagnetic simulation model;
  • the second model building module is configured to randomly distribute the lipid particles in the blood electromagnetic simulation model according to the calculation result, and establish a blood electromagnetic simulation model with variable blood lipid concentration by controlling the number of blood lipid particles.
  • the technical solution adopted by the embodiment of the present invention further includes: the formula for calculating the number of blood lipid particles in the blood electromagnetic simulation model by the blood lipid particle number calculation module is:
  • n is the number of blood lipid particles
  • N is the number of neutral fat molecules and lipid molecules
  • is the blood lipid concentration
  • V is the blood volume
  • M ⁇ ⁇ V / 1000
  • N A 6.02 ⁇ 10 23
  • V 1000 ⁇ ⁇ (d / 2) 2 ⁇ h.
  • the technical solution adopted by the embodiment of the present invention further includes: the method for establishing the blood electromagnetic simulation model with variable blood lipid concentration by the second model establishing module comprises: generating n random numbers uniformly distributed between (-1, 1) ⁇ 1 , ⁇ 1 , ⁇ 1 ,..., ⁇ n ⁇ ; According to the central limit theorem of probability theory, a random value obeying the normal distribution N( ⁇ , ⁇ ) is generated, and the formula for generating a random value is:
  • the position of each blood lipid particle in the blood electromagnetic simulation model is determined, and a blood electromagnetic simulation model with variable blood lipid concentration is established; in the above formula, ⁇ i is a uniformly distributed random number, and ⁇ is a normal distribution.
  • the expected value of the random number, ⁇ is the mean square error of the normal distribution random number, and n is the number of uniformly distributed random numbers required to generate the normal distribution random number.
  • the technical solution adopted by the embodiment of the present invention further includes a parameter calculation module, wherein the parameter calculation module is configured to fit the electromagnetic parameters of the blood layer and the blood vessel layer in the blood electromagnetic simulation model by using the triple debye-drude model, and the fitting result is obtained.
  • the blood electromagnetic simulation model is numerically calculated.
  • the beneficial effects of the embodiments of the present invention are: the method and device for establishing a blood electromagnetic simulation model in the embodiment of the present invention, according to the concentration of blood lipids and the volume of blood in the blood electromagnetic simulation model. Calculate the number of blood lipid particles in the blood electromagnetic simulation model, and establish a blood electromagnetic simulation model with variable blood lipid concentration by controlling the number of blood lipid particles; and use the triple debye-drude model to analyze the electromagnetic parameters of different tissue layers in the blood electromagnetic simulation model. A fitting is performed to set its electromagnetic parameters.
  • the blood electromagnetic simulation model established by the invention can be used to analyze the interaction mechanism between blood lipids and electromagnetic waves, obtain electromagnetic wave response characteristics under different blood lipid concentrations, and provide important theoretical support for the development of non-invasive blood lipid detection technology.
  • the invention has the advantages of low use cost, high simulation precision and the like.
  • FIG. 1 is a flow chart of a method for establishing a blood electromagnetic simulation model according to an embodiment of the present invention
  • FIG. 2 is a schematic diagram showing the overall structure of a blood electromagnetic simulation model according to an embodiment of the present invention
  • Figure 3 is a blood electromagnetic simulation model of different blood lipid concentrations established using blood lipid particles
  • FIG. 4 is a schematic structural view of an apparatus for establishing a blood electromagnetic simulation model according to an embodiment of the present invention.
  • FIG. 1 is a flowchart of a method for establishing a blood electromagnetic simulation model according to an embodiment of the present invention.
  • the method for establishing a blood electromagnetic simulation model according to an embodiment of the present invention includes the following steps:
  • Step 100 Determine an overall structure of a blood electromagnetic simulation model
  • step 100 the overall structure of the blood electromagnetic simulation model is determined by:
  • Step 110 According to the principle of human anatomy, study the distribution of blood vessels and blood in the human body, abstract the blood vessels and blood, and determine the overall structure of the blood electromagnetic simulation model;
  • the blood electromagnetic simulation model includes three parts: a blood vessel layer, a blood layer, and a blood lipid particle layer; in the embodiment of the invention, the overall structure of the blood electromagnetic simulation model is a cylinder.
  • the overall structure of the blood electromagnetic simulation model is a cylinder.
  • FIG. 2 it is a schematic diagram of the overall structure of a blood electromagnetic simulation model according to an embodiment of the present invention. In other embodiments of the invention, the overall structure of the blood electromagnetic simulation model may also be other shapes.
  • Step 120 respectively determining a distribution position of a blood vessel layer, a blood layer, and a blood lipid particle layer in a blood electromagnetic simulation model
  • the lipid particle layer is distributed in the blood layer.
  • Step 200 Establish a blood vessel electromagnetic simulation model, a blood electromagnetic simulation model, and a blood lipid particle electromagnetic simulation model according to the distribution positions of the blood vessel layer, the blood layer, and the blood lipid particle layer;
  • a blood vessel electromagnetic simulation model, a blood electromagnetic simulation model, and a blood lipid particle electromagnetic simulation The way the true model is built includes:
  • Step 220 Establish a blood electromagnetic simulation model: a cylinder having a length h and a radius of d/2 is established with the origin as a center, and the cylinder is a blood electromagnetic simulation model;
  • Step 230 Establish an electromagnetic simulation model of blood lipid particles
  • step 230 since the blood lipids in the human blood are mainly composed of neutral fat molecules (triglycerides and cholesterol) and lipid molecules (phospholipids, glycolipids, sterols, steroids), and neutral fat molecules and lipids.
  • the average radius of the molecules is typically only 50 nm. If a blood electromagnetic simulation model is established based on this size and electromagnetic simulation is performed at this size, the mesh division is required to be very fine, resulting in a very large amount of calculation.
  • the embodiment of the present invention compares the neutral fat molecule and the lipid molecule in the blood into blood lipid particles in the modeling process, and the equivalent calculation method is as follows:
  • the shapes of the neutral fat molecules and the lipid molecules in the human blood are all spheres, and the size is the same, and the radius is r r .
  • the shape of the electromagnetic simulation model of the lipid particles to be established is established. Set to the sphere, the radius is R r , then there is
  • Step 300 Calculate the number of blood lipid particles in the blood electromagnetic simulation model according to the concentration of blood lipids and the volume of blood in the blood electromagnetic simulation model;
  • step 300 the method for calculating the number of blood lipid particles specifically includes:
  • the number of blood lipid particles in the blood electromagnetic simulation model corresponding to different blood lipid concentrations can be calculated. Therefore, in the blood electromagnetic simulation model, a blood electromagnetic simulation model with variable blood lipid concentration can be established by changing the number n of blood lipid particles.
  • Step 400 According to the calculation result, the blood lipid particles are randomly distributed in the blood electromagnetic simulation model according to the principle of normal random distribution, and a blood electromagnetic simulation model with variable blood lipid concentration is established by controlling the number of blood lipid particles;
  • a specific manner of establishing a blood electromagnetic simulation model with variable blood lipid concentration includes:
  • Step 410 Generate n random numbers ⁇ 1 , ⁇ 1 , ⁇ 1 , ..., ⁇ n ⁇ uniformly distributed between (-1, 1 );
  • Step 420 According to the central limit theorem in probability theory, generate a compliance positive according to formula (3) Random values of the state distribution N( ⁇ , ⁇ ):
  • ⁇ i is a uniformly distributed random number
  • is the expected value of a normal distribution random number
  • is the mean square error of a normal distribution random number
  • n is a uniform distribution random required to generate a normal distribution random number The number of the number.
  • Step 430 Determine the position of each blood lipid particle in the blood electromagnetic simulation model according to formula (3), and finally establish a blood electromagnetic simulation model with variable blood lipid concentration, as shown in FIG. 3, for different blood lipid concentrations established by using blood lipid particles. Blood electromagnetic simulation model.
  • Step 500 Using the triple debye-drude model to fit the electromagnetic parameters of different tissue layers (blood, blood vessels) in the blood electromagnetic simulation model, and introducing the fitting result into the blood electromagnetic simulation model, and performing numerical calculation on the blood electromagnetic simulation model ;
  • electromagnetic parameters are also set in the blood layer and the blood vessel layer in the model, and the electromagnetic parameters include a dielectric constant and a conductivity. Since both blood and blood vessels are dispersive media, their dielectric constant and conductivity change with frequency. In the electromagnetic simulation process, the traditional Cole-Cole model can only be applied to the simulation of a single frequency, and it is powerless in the wide frequency band. Therefore, in the embodiment of the present invention, the debye-drude model is used to fit the dielectric constant and the electrical conductivity of the blood layer and the blood vessel layer, and the relevant parameters are introduced into the corresponding tissue layer after the fitting is completed.
  • the electromagnetic parameter fitting method specifically includes:
  • Step 510 Obtain real and imaginary values of the complex permittivity of the blood layer and the blood vessel layer by using a quadruple Cole-Cole model;
  • the embodiment of the present invention utilizes the blood quadruple Cole-Cole model provided by REMCOM, and calculates the blood layer and the blood vessel layer in the frequency range of 10 Hz to 20 GHz as shown in the formula (4).
  • the real part value and the imaginary part value of the complex permittivity, wherein the real part value corresponds to the dielectric constant, the imaginary part value corresponds to the conductivity, and the real part value and the imaginary part value are respectively imported into the Origin software as input values.
  • Step 520 Establish a triple debye-drude model, and use the triple debye-drude model to fit the real and imaginary values of the complex permittivity of the blood layer and the blood vessel layer respectively; the fitting formula is as follows:
  • Step 530 Determine parameters to be fitted in the blood layer and the blood vessel layer in the triple debye-drude model; perform rational decomposition on the triple debye-drude model to calculate the real part ( ⁇ ') and the imaginary part ( ⁇ ′′) respectively.
  • Polynomial the formula is as follows:
  • Step 540 Establish corresponding nonlinear curves y1 and y2 in the Origin software.
  • Y2 (b ⁇ 2 ⁇ 3.1415926 ⁇ f ⁇ c)/(1+(2 ⁇ 3.1415926 ⁇ f ⁇ c) ⁇ 2)+(d ⁇ 2 ⁇ 3.1415926 ⁇ f ⁇ e)/(1+(2 ⁇ 3.1415926 ⁇ f ⁇ e) ⁇ 2)+
  • Step 550 using the initial values in the Cole-Cole model to respectively assign initial values of the a, b, c, d, e, g, h, k parameters to the iterative fitting, and using the Origin software to perform parameter fitting;
  • Step 560 Substituting the parameter fitting results of the blood layer and the blood vessel layer into the Debye-Drude triple pole model respectively, and then using the Origin software to perform error analysis on the parameter fitting results of the blood layer and the blood vessel layer;
  • Step 570 Introduce the parameter fitting result of the blood layer and the blood vessel layer into the blood electromagnetic simulation model, and perform numerical calculation on the blood electromagnetic simulation model.
  • FIG. 4 is a schematic structural diagram of an apparatus for establishing a blood electromagnetic simulation model according to an embodiment of the present invention.
  • the device for establishing a blood electromagnetic simulation model according to an embodiment of the invention comprises a structural calculation module, a first model establishment module, a blood lipid particle number calculation module, a second model establishment module and a parameter calculation module.
  • Structural calculation module used to determine the overall structure of the blood electromagnetic simulation model according to the anatomy of human body; wherein the overall structure of the blood electromagnetic simulation model is determined as follows: First, according to the principle of human anatomy, the distribution of blood vessels and blood in the human body is studied. In the case, the blood vessel and blood are abstracted to determine the overall structure of the blood electromagnetic simulation model.
  • the blood electromagnetic simulation model includes three parts: blood vessel, blood and blood lipid particles.
  • the first model establishing module is configured to respectively establish a blood vessel electromagnetic simulation model, a blood electromagnetic simulation model and a blood lipid particle electromagnetic simulation model according to the distribution positions of blood vessels, blood and blood lipid particles; specifically, the first model establishing module includes a blood vessel model establishing unit, a blood model building unit and a blood lipid particle model building unit;
  • Blood model building unit used to establish a blood electromagnetic simulation model: a cylinder with a length h and a radius of d/2 is established with the origin as the center, and the cylinder is a blood electromagnetic simulation model;
  • Blood lipid particle model building unit used to establish an electromagnetic simulation model of blood lipid particles: Since the blood lipids in human blood are mainly composed of neutral fat molecules and lipid molecules, the average radius of neutral fat molecules and lipid molecules is generally only 50 nm. . If a blood electromagnetic simulation model is established based on this size and electromagnetic simulation is performed at this size, the mesh division is required to be very fine, resulting in a very large amount of calculation. In order to reduce the amount of calculation and speed up the simulation without affecting the simulation precision, the embodiment of the present invention compares the neutral fat molecule and the lipid molecule in the blood into blood lipid particles in the modeling process, and the equivalent calculation method is as follows:
  • the shapes of the neutral fat molecules and the lipid molecules in the human blood are all spheres, and the size is the same, and the radius is r r .
  • the shape of the electromagnetic simulation model of the lipid particles to be established is established. Set to the sphere, the radius is R r , then there is
  • Blood lipid particle number calculation module used to calculate the number of blood lipid particles in the blood electromagnetic simulation model according to the concentration of blood lipids and the blood volume in the blood electromagnetic simulation model; the blood lipid particle number calculation module specifically includes a blood volume calculation unit and a blood lipid concentration calculation unit And a number of blood lipid particles calculation unit;
  • V is a cylinder
  • d/2 is the radius of the cylinder
  • h is the length of the cylinder
  • the units of d/2 and h are m.
  • the number of blood lipid particles in the blood electromagnetic simulation model corresponding to different blood lipid concentrations can be calculated. Therefore, in the blood electromagnetic simulation model, a blood electromagnetic simulation model with variable blood lipid concentration can be established by changing the number n of blood lipid particles.
  • the second model building module is configured to randomly distribute the blood lipid particles according to the normal distribution principle in the blood electromagnetic simulation model according to the calculation result, and establish a blood electromagnetic simulation model with variable blood lipid concentration by controlling the number of blood lipid particles;
  • the specific method of the second model building module to establish a blood electromagnetic simulation model with variable blood lipid concentration includes:
  • ⁇ i is a uniformly distributed random number
  • is the expected value of a normal distribution random number
  • is the mean square error of a normal distribution random number
  • n is a uniform distribution random required to generate a normal distribution random number The number of the number.
  • Parameter calculation module used to fit the electromagnetic parameters of different tissue layers (blood, blood vessels) in the blood electromagnetic simulation model by using the triple debye-drude model, and introduce the fitting result into the blood electromagnetic simulation model, and the blood electromagnetic simulation model Numerical calculations are performed; wherein the electromagnetic parameters include dielectric constant and electrical conductivity, and since both blood and blood vessels belong to a dispersive medium, their dielectric constant and electrical conductivity change with frequency.
  • the traditional Cole-Cole model can only be applied to the simulation of a single frequency, and it is powerless in the wide frequency band.
  • the debye-drude model is used to fit the dielectric constant and the electrical conductivity of the blood layer and the blood vessel layer, and the relevant parameters are introduced into the corresponding tissue layer after the fitting is completed.
  • the electromagnetic parameter fitting method specifically includes:
  • the real and imaginary values of the complex permittivity of the blood and vascular layers are separately obtained by the quadruple Cole-Cole model; the embodiment of the present invention utilizes the blood quadruple Cole-Cole model provided by REMCOM, such as the formula ( 4) Calculate the real and imaginary values of the complex permittivity of the blood and vascular layers in the frequency range of 10 Hz to 20 GHz.
  • the real part corresponds to the dielectric constant
  • the imaginary part corresponds to Conductivity
  • the real and imaginary values are imported into the Origin software as input values.
  • Y2 (b ⁇ 2 ⁇ 3.1415926 ⁇ f ⁇ c)/(1+(2 ⁇ 3.1415926 ⁇ f ⁇ c) ⁇ 2)+(d ⁇ 2 ⁇ 3.1415926 ⁇ f ⁇ e)/(1+(2 ⁇ 3.1415926 ⁇ f ⁇ e) ⁇ 2)+
  • the method and device for establishing a blood electromagnetic simulation model according to an embodiment of the present invention are in the modeling process, according to The concentration of blood lipids and the volume of blood in the blood electromagnetic simulation model, calculate the number of blood lipid particles in the blood electromagnetic simulation model, establish a blood electromagnetic simulation model with variable blood lipid concentration by controlling the number of blood lipid particles, and use the triple debye-drude model.
  • the electromagnetic parameters of different tissue layers in the blood electromagnetic simulation model are fitted to set the electromagnetic parameters.
  • the blood electromagnetic simulation model established by the invention can be used to analyze the interaction mechanism between blood lipids and electromagnetic waves, obtain electromagnetic wave response characteristics under different blood lipid concentrations, and provide important theoretical support for the development of non-invasive blood lipid detection technology. At the same time, the invention has the advantages of low use cost, high simulation precision and the like.

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Hardware Design (AREA)
  • Evolutionary Computation (AREA)
  • Geometry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

一种建立血液电磁仿真模型的方法及装置,涉及血脂检测技术领域。建立血液电磁仿真模型的方法包括:步骤a:建立血液电磁仿真模型(100);步骤b:根据血脂的浓度和血液电磁仿真模型中血液的体积,计算血液电磁仿真模型中血脂粒子的数目(300);步骤c:根据计算结果将血脂粒子随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型(400)。该方法可用于分析血脂与电磁波的相互作用机理,获取在不同血脂浓度下的电磁波响应特性,为无创血脂检测技术的发展提供重要的理论支撑。同时,还具有使用成本低、仿真精度高等优点。

Description

一种建立血液电磁仿真模型的方法及装置 技术领域
本发明涉及血脂检测技术领域,特别涉及一种建立血液电磁仿真模型的方法及装置。
背景技术
血脂是血液中的中性脂肪(甘油三酯和胆固醇)和类脂(磷脂、糖脂、固醇、类固醇)的总称,广泛存在于人体中。它们是生命细胞的基础代谢必需物质。血脂异常者往往伴有多种心血管危险因素,甚至会导致一些严重危害人体健康的疾病,如动脉粥样硬化、冠心病、胰腺炎等。为了提高人们健康生活水平,对血脂进行检测是非常重要的。
无创血脂检测法是一种利用电磁波的反射、透射来获取患者的血脂浓度的方法,因此无需采集患者的血液,具有无创、简便、快速等的优势。建立血脂检测模型是研究无创血脂检测技术的前提。目前,在血脂建模研究方面,研究者主要采用实验统计方法对血脂进行建模,即通过实验动物研究在不同喂养方式下其血脂变化情况,从而建立高血脂症等医学模型。例如,中国专利CN103299950A公开了一种食蟹猴高血脂症和动脉粥样硬化模型的建立方法,该方法主要通过给食蟹猴喂养高脂饲料,根据食蟹猴的生化指标变化完成高血脂症模型的建立。另一中国专利CN102907357A公开了一种斑马鱼高血脂症模型的构建方法,该方法通过利用蛋黄粉喂养斑马鱼,使斑马鱼组织化学染色或荧光染色,并获取相关图像,对图像/微孔板进行分析和统计,最终建立斑马鱼的高血脂症模型。
然而,上述采用实验统计的方法所建立的高血脂症等医学模型只适用于研 究血脂的变化规律,不能用于分析血脂与电磁波的相互作用机理,因此无法为无创血脂检测技术提供理论支撑。
发明内容
本发明提供了一种建立血液电磁仿真模型的方法及装置,旨在至少在一定程度上解决现有技术中的上述技术问题之一。
为了解决上述问题,本发明提供了如下技术方案:
一种建立血液电磁仿真模型的方法,包括:
步骤a:建立血液电磁仿真模型;
步骤b:根据血脂的浓度和血液电磁仿真模型中血液的体积,计算血液电磁仿真模型中血脂粒子的数目;
步骤c:根据计算结果将血脂粒子随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型。
本发明实施例采取的技术方案还包括:所述步骤a前还包括:确定血液电磁仿真模型的整体结构;所述血液电磁仿真模型的整体结构为圆柱体,所述血液电磁仿真模型包括血管层、血液层和血脂粒子层,所述血管层、血液层和血脂粒子层的分布位置分别为:血管层位于最外层,血管层的长度为h,血管层的内径为d,外径为D,血管层的厚度为r12=(D-d)/2;血液层位于血管层中,血液层的半径为r=d/2;血脂粒子层分布在血液层中。
本发明实施例采取的技术方案还包括:在所述步骤b中,所述血液电磁仿真模型中血脂粒子数目的计算公式为:
Figure PCTCN2016103033-appb-000001
上述公式中,n为血脂粒子的数目,N为中性脂肪分子和类脂分子的数目,ρ为血脂浓度,V为血液体积,M=ρ×V/1000,NA=6.02×1023,V=1000×π(d/2)2×h。
本发明实施例采取的技术方案还包括:在所述步骤c中,所述建立血脂浓度可变的血液电磁仿真模型具体包括:
步骤c1:生成n个在(-1,1)间均匀分布的随机数{ζ111,...,ζn};
步骤c2:依据概率理论的中心极限定理,生成一个服从正态分布N(μ,σ)的随机值,生成随机值的公式为:
Figure PCTCN2016103033-appb-000002
在上述公式中,ζi为均匀分布随机数,μ是正态分布随机数的期望值,σ是正态分布随机数的均方差,n是产生正态分布随机数所需的均匀分布随机数的个数;
步骤c3:根据上述生成随机值的公式确定在血液电磁仿真模型中每个血脂粒子的位置,建立血脂浓度可变的血液电磁仿真模型。
本发明实施例采取的技术方案还包括:所述步骤c后还包括:利用三重debye-drude模型对血液电磁仿真模型中血液层和血管层的电磁参数进行拟合,并将拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算。
本发明实施例采取的另一技术方案为:一种建立血液电磁仿真模型的装置,包括:
第一模型建立模块:用于建立血液电磁仿真模型;
血脂粒子数目计算模块:用于根据血脂的浓度和血液电磁仿真模型中血液的体积,计算血液电磁仿真模型中血脂粒子的数目;
第二模型建立模块:用于根据计算结果将血脂粒子随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型。
本发明实施例采取的技术方案还包括结构计算模块,所述结构计算模块用于确定血液电磁仿真模型的整体结构;所述血液电磁仿真模型的整体结构为圆柱体,所述血液电磁仿真模型包括血管层、血液层和血脂粒子层,所述血管层、血液层和血脂粒子层的分布位置分别为:血管层位于最外层,血管层的长度为h,血管层的内径为d,外径为D,血管层的厚度为r12=(D-d)/2;血液层位于血管层中,血液层的半径为r=d/2;血脂粒子层分布在血液层中。
本发明实施例采取的技术方案还包括:所述血脂粒子数目计算模块计算血液电磁仿真模型中血脂粒子数目的公式为:
Figure PCTCN2016103033-appb-000003
上述公式中,n为血脂粒子的数目,N为中性脂肪分子和类脂分子的数目,ρ为血脂浓度,V为血液体积,M=ρ×V/1000,NA=6.02×1023,V=1000×π(d/2)2×h。
本发明实施例采取的技术方案还包括:所述第二模型建立模块建立血脂浓度可变的血液电磁仿真模型的方式包括:生成n个在(-1,1)间均匀分布的随机数{ζ111,...,ζn};依据概率理论的中心极限定理,生成一个服从正态分布N(μ,σ)的随机值,生成随机值的公式为:
Figure PCTCN2016103033-appb-000004
根据上述生成随机值的公式确定在血液电磁仿真模型中每个血脂粒子的位置,建立血脂浓度可变的血液电磁仿真模型;在上述公式中,ζi为均匀分布 随机数,μ是正态分布随机数的期望值,σ是正态分布随机数的均方差,n是产生正态分布随机数所需的均匀分布随机数的个数。
本发明实施例采取的技术方案还包括参数计算模块,所述参数计算模块用于利用三重debye-drude模型对血液电磁仿真模型中血液层和血管层的电磁参数进行拟合,并将拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算。
相对于现有技术,本发明实施例产生的有益效果在于:本发明实施例的建立血液电磁仿真模型的方法及装置在建模过程中,根据血脂的浓度和血液电磁仿真模型中血液体积的大小,计算血液电磁仿真模型中血脂粒子的数目,通过控制血脂粒子的数目,从而建立血脂浓度可变的血液电磁仿真模型;并利用三重debye-drude模型对血液电磁仿真模型中不同组织层的电磁参数进行拟合,从而设定其电磁参数。通过本发明建立的血液电磁仿真模型可用于分析血脂与电磁波的相互作用机理,获取在不同血脂浓度下的电磁波响应特性,为无创血脂检测技术的发展提供重要的理论支撑。同时,本发明还具有使用成本低、仿真精度高等优点。
附图说明
图1是本发明实施例的建立血液电磁仿真模型的方法的流程图;
图2为本发明实施例的血液电磁仿真模型的整体结构示意图;
图3为利用血脂粒子建立的不同血脂浓度的血液电磁仿真模型;
图4是本发明实施例的建立血液电磁仿真模型的装置的结构示意图。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。
请参阅图1,是本发明实施例的建立血液电磁仿真模型的方法的流程图。本发明实施例的建立血液电磁仿真模型的方法包括以下步骤:
步骤100:确定血液电磁仿真模型的整体结构;
在步骤100中,血液电磁仿真模型整体结构的确定方式包括:
步骤110:根据人体解剖学原理,研究血管与血液在人体的分布情况,对血管与血液进行抽象化处理,确定血液电磁仿真模型的整体结构;
在步骤110中,血液电磁仿真模型包括血管层、血液层和血脂粒子层三个部分;本发明实施例中,该血液电磁仿真模型的整体结构为圆柱体。具体如图2所示,为本发明实施例的血液电磁仿真模型的整体结构示意图。在本发明其他实施例中,血液电磁仿真模型的整体结构还可以是其他形状。
步骤120:分别确定血管层、血液层和血脂粒子层在血液电磁仿真模型中的分布位置;
在步骤120中,血管层、血液层和血脂粒子层在血液电磁仿真模型中的分布位置分别为:血管层位于最外层,且血管层的长度为h,血管层的内径为d,外径为D,因此血管层的厚度为r12=(D-d)/2。血液层位于血管层中,因此血液层的半径为r=d/2。血脂粒子层则分布在血液层中。
步骤200:根据血管层、血液层和血脂粒子层的分布位置分别建立血管电磁仿真模型、血液电磁仿真模型和血脂粒子电磁仿真模型;
在步骤200中,血管电磁仿真模型、血液电磁仿真模型和血脂粒子电磁仿 真模型的建立方式分别包括:
步骤210:建立血管电磁仿真模型:以原点为圆心,建立长度为h,半径分别为d/2和D/2的圆柱体,将这两个圆柱体进行相减运算,从而获得一个内部中空,厚度为r12=(D-d)/2的血管电磁仿真模型;
步骤220:建立血液电磁仿真模型:以原点为圆心,建立长度为h,半径为d/2的圆柱体,该圆柱体即为血液电磁仿真模型;
步骤230:建立血脂粒子电磁仿真模型;
在步骤230中,由于人体血液中的血脂主要是由中性脂肪分子(甘油三酯和胆固醇)和类脂分子(磷脂、糖脂、固醇、类固醇)组成,且中性脂肪分子和类脂分子的平均半径一般仅为50nm。如果根据此尺寸建立血液电磁仿真模型,并以此尺寸进行电磁仿真,则需将网格划分非常精细,导致计算量非常庞大。为了减少计算量,加快仿真速度,同时又不影响仿真精度,本发明实施例在建模过程中,将血液中的中性脂肪分子和类脂分子等效为血脂粒子,等效计算方法如下:
为了简化计算,假设人体血液中的中性脂肪分子和类脂分子的形状均为球体,且尺寸大小一样,其半径为rr,在电磁仿真模型中,将要建立的血脂粒子电磁仿真模型的形状设为球体,其半径为Rr,则有
Figure PCTCN2016103033-appb-000005
在公式(1)中,N为中性脂肪分子和类脂分子的数目。由于中性脂肪分子和类脂分子的半径一般为50nm,即rr=50nm,在血液电磁仿真模型中,当将血脂粒子的半径设置为0.5mm,即Rr=0.5mm,根据公式(1)可计算得出N=1×1012,即在建模过程中,将每1×1012个血脂分子等效为一个直径约为0.5mm的血脂粒子,从而大大减少仿真计算量。
步骤300:根据血脂的浓度和血液电磁仿真模型中血液体积的大小,计算血液电磁仿真模型中血脂粒子的数目;
在步骤300中,血脂粒子数目的计算方法具体包括:
步骤310:计算血液电磁仿真模型中血液的体积:由于血液电磁仿真模型为圆柱体,其体积可表示为:V=1000×π(d/2)2×h,其中V为圆柱体的体积,单位为L,d/2为圆柱体的半径,h为圆柱体的长度,d/2和h的单位均为m。
步骤320:假设血脂的平均浓度为ρ,其单位为mmol/L,当血液的体积为V=1000×π(d/2)2×h,血脂分子(即中性脂肪分子和类脂分子)的物质的量则为M=ρ×V/1000,其中M的单位为mol。
步骤330:根据阿伏伽德罗常数可知,每1mol的物质含有6.02×1023个分子,即NA=6.02×1023,因此,当血脂浓度为ρ,血液体积为V时,血液电磁仿真模型中血脂粒子的数目为
Figure PCTCN2016103033-appb-000006
根据公式(2),可计算出不同血脂浓度时所对应的血液电磁仿真模型中的血脂粒子的数目。因此,在血液电磁仿真模型中,可通过改变血脂粒子的数目n,从而建立血脂浓度可变的血液电磁仿真模型。
步骤400:根据计算结果将血脂粒子按正态随机分布原理,随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型;
在步骤400中,建立血脂浓度可变的血液电磁仿真模型的具体方式包括:
步骤410:生成n个在(-1,1)间均匀分布的随机数{ζ111,...,ζn};
步骤420:依据概率理论中的中心极限定理,按公式(3)生成一个服从正 态分布N(μ,σ)的随机值:
Figure PCTCN2016103033-appb-000007
在公式(3)中,ζi为均匀分布随机数,μ是正态分布随机数的期望值,σ是正态分布随机数的均方差,n是产生正态分布随机数所需的均匀分布随机数的个数。
步骤430:根据公式(3)确定在血液电磁仿真模型中每个血脂粒子的位置,最终建立血脂浓度可变的血液电磁仿真模型,如图3所示,为利用血脂粒子建立的不同血脂浓度的血液电磁仿真模型。
步骤500:利用三重debye-drude模型对血液电磁仿真模型中不同组织层(血液、血管)的电磁参数进行拟合,并将拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算;
在步骤500中,建立血液电磁仿真模型后,还需对该模型中的血液层和血管层设定电磁参数,电磁参数包括介电常数和电导率。由于血液和血管均属于色散介质,其介电常数和电导率会随着频率发生改变。在电磁仿真过程中,传统的Cole-Cole模型只能适用于单一频率的仿真,在宽频带时无能为力。因此,本发明实施例采用debye-drude模型来对血液层和血管层的介电常数和电导率进行拟合,拟合完毕后再将相关参数导入到相应的组织层中。电磁参数拟合方式具体包括:
步骤510:通过四重Cole-Cole模型分别获取血液层和血管层的复介电常数的实部值与虚部值;
在步骤510中,本发明实施例利用REMCOM公司提供的血液四重Cole-Cole模型,如公式(4)所示,计算求出10Hz-20GHz频段范围内血液层和血管层的 复介电常数的实部值与虚部值,其中实部值对应的是介电常数,虚部值对应的是电导率,并将实部值与虚部值分别导入Origin软件作为输入值。
Figure PCTCN2016103033-appb-000008
步骤520:建立三重debye-drude模型,采用三重debye-drude模型对所获取的血液层和血管层的复介电常数的实部值与虚部值分别进行拟合;拟合公式如下:
Figure PCTCN2016103033-appb-000009
步骤530:确定在三重debye-drude模型中血液层和血管层需拟合的参数;对三重debye-drude模型进行有理式分解,分别计算实部(ε′)、虚部(ε″)对应的多项式,计算公式如下:
Figure PCTCN2016103033-appb-000010
Figure PCTCN2016103033-appb-000011
确定需要拟合的参数包括:ε=a、Δε1=b、τ1=c、Δε2=d、τ2=e、Δε3=g、τ3=h、σi=k;
步骤540:在Origin软件中建立对应的非线性曲线y1、y2,
y1=ε′                (8)
y2=ε"               (9)
其中,
y1=a+b/(1+(2×3.1415926×f×c)^2)+d/(1+(2*3.1415926*f*e)^2)+
g/(1+(2×3.1415926×f×h)^2)                 (10)
y2=(b×2×3.1415926×f×c)/(1+(2×3.1415926×f×c)^2)+(d×2×3.1415926×f×e)/(1+(2×3.1415926×f×e)^2)+
(g×2×3.1415926×f×h)/(1+(2×3.1415926×f×h)^2)+k/(2×3.1415926×f×8.85418×pow(10,-12))  (11)
步骤550:采用Cole-Cole模型中的初始值分别对a、b、c、d、e、g、h、k参数赋迭代拟合的初始值,利用Origin软件进行参数拟合;
步骤560:将血液层和血管层的参数拟合结果分别代入Debye-Drude三重极点模型中,然后利用Origin软件对血液层和血管层的参数拟合结果进行误差分析;
步骤570:将血液层和血管层的参数拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算。
请参阅图4,是本发明实施例的建立血液电磁仿真模型的装置的结构示意图。本发明实施例的建立血液电磁仿真模型的装置包括结构计算模块、第一模型建立模块、血脂粒子数目计算模块、第二模型建立模块和参数计算模块。
结构计算模块:用于根据人体解剖学原理确定血液电磁仿真模型的整体结构;其中,血液电磁仿真模型整体结构的确定方式具体为:首先,根据人体解剖学原理,研究血管与血液在人体的分布情况,对血管与血液进行抽象化处理,确定血液电磁仿真模型的整体结构,其中,血液电磁仿真模型包括血管、血液和血脂粒子三个部分。然后,分别确定血管、血液和血脂粒子在血液电磁仿真模型中的分布位置;其中,血管、血液和血脂粒子在血液电磁仿真模型中的分布位置分别为:血管位于最外层,且血管的长度为h,血管的内径为d,外径为D,因此血管的厚度为r12=(D-d)/2。血液位于血管中,因此血液的半径为r=d/2。血脂粒子则分布在血液中。
第一模型建立模块:用于根据血管、血液和血脂粒子的分布位置分别建立血管电磁仿真模型、血液电磁仿真模型和血脂粒子电磁仿真模型;具体地,第一模型建立模块包括血管模型建立单元、血液模型建立单元和血脂粒子模型建立单元;
血管模型建立单元:用于建立血管电磁仿真模型:以原点为圆心,建立长度为h,半径分别为d/2和D/2的圆柱体,将这两个圆柱体进行相减运算,从而获得一个内部中空,厚度为r12=(D-d)/2的血管电磁仿真模型;
血液模型建立单元:用于建立血液电磁仿真模型:以原点为圆心,建立长度为h,半径为d/2的圆柱体,该圆柱体即为血液电磁仿真模型;
血脂粒子模型建立单元:用于建立血脂粒子电磁仿真模型:由于人体血液中的血脂主要是由中性脂肪分子和类脂分子组成,且中性脂肪分子和类脂分子的平均半径一般仅为50nm。如果根据此尺寸建立血液电磁仿真模型,并以此尺寸进行电磁仿真,则需将网格划分非常精细,导致计算量非常庞大。为了减少计算量,加快仿真速度,同时又不影响仿真精度,本发明实施例在建模过程中,将血液中的中性脂肪分子和类脂分子等效为血脂粒子,等效计算方法如下:
为了简化计算,假设人体血液中的中性脂肪分子和类脂分子的形状均为球体,且尺寸大小一样,其半径为rr,在电磁仿真模型中,将要建立的血脂粒子电磁仿真模型的形状设为球体,其半径为Rr,则有
Figure PCTCN2016103033-appb-000012
在公式(1)中,N为中性脂肪分子和类脂分子的数目。由于中性脂肪分子和类脂分子的半径一般为50nm,即rr=50nm,在血液电磁仿真模型中,当将血脂粒子的半径设置为0.5mm,即Rr=0.5mm,根据公式(1)可计算得出N=1×1012,即在建模过程中,将每1×1012个血脂分子等效为一个直径约为0.5mm的血脂粒子,从而大大减少仿真计算量。
血脂粒子数目计算模块:用于根据血脂的浓度和血液电磁仿真模型中血液体积的大小,计算血液电磁仿真模型中血脂粒子的数目;血脂粒子数目计算模块具体包括血液体积计算单元、血脂浓度计算单元和血脂粒子数目计算单元;
血液体积计算单元:用于计算血液电磁仿真模型中血液的体积:由于血液电磁仿真模型为圆柱体,其体积可表示为:V=1000×π(d/2)2×h,其中V为圆柱体的体积,单位为L,d/2为圆柱体的半径,h为圆柱体的长度,d/2和h的单位均为m。
血脂浓度计算单元:用于计算血脂浓度,假设血脂的平均浓度为ρ,其单位为mmol/L,当血液的体积为V=1000×π(d/2)2×h,血脂分子(即中性脂肪分子和类脂分子)的物质的量则为M=ρ×V/1000,其中M的单位为mol。
血脂粒子数目计算单元:用于根据血液体积和血脂浓度计算血液电磁仿真模型中血脂粒子的数目;根据阿伏伽德罗常数可知,每1mol的物质含有6.02×1023个分子,即NA=6.02×1023,因此,当血脂浓度为ρ,血液体积为V时,血液电磁仿真模型中血脂粒子的数目为
Figure PCTCN2016103033-appb-000013
根据公式(2),可计算出不同血脂浓度时所对应的血液电磁仿真模型中的血脂粒子的数目。因此,在血液电磁仿真模型中,可通过改变血脂粒子的数目n,从而建立血脂浓度可变的血液电磁仿真模型。
第二模型建立模块:用于根据计算结果将血脂粒子按正态随机分布原理,随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型;其中,第二模型建立模块建立血脂浓度可变的血液电磁仿真模型的具体方式包括:
1:生成n个在(-1,1)间均匀分布的随机数{ζ111,...,ζn};
2:依据概率理论中的中心极限定理,按公式(3)生成一个服从正态分布N(μ,σ)的随机值:
Figure PCTCN2016103033-appb-000014
在公式(3)中,ζi为均匀分布随机数,μ是正态分布随机数的期望值,σ是正态分布随机数的均方差,n是产生正态分布随机数所需的均匀分布随机数的个数。
3:根据公式(3)确定在血液电磁仿真模型中每个血脂粒子的位置,最终建立血脂浓度可变的血液电磁仿真模型。
参数计算模块:用于利用三重debye-drude模型对血液电磁仿真模型中不同组织层(血液、血管)的电磁参数进行拟合,并将拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算;其中,电磁参数包括介电常数和电导率,由于血液和血管均属于色散介质,其介电常数和电导率会随着频率发生改变。在电磁仿真过程中,传统的Cole-Cole模型只能适用于单一频率的仿真,在宽频带时无能为力。因此,本发明实施例采用debye-drude模型来对血液层和血管层的介电常数和电导率进行拟合,拟合完毕后再将相关参数导入到相应的组织层中。电磁参数拟合方式具体包括:
1:通过四重Cole-Cole模型分别获取血液层和血管层的复介电常数的实部值与虚部值;本发明实施例利用REMCOM公司提供的血液四重Cole-Cole模型,如公式(4)所示,计算求出10Hz-20GHz频段范围内血液层和血管层的复介电常数的实部值与虚部值,其中实部值对应的是介电常数,虚部值对应的是电导率,并将实部值与虚部值分别导入Origin软件作为输入值。
Figure PCTCN2016103033-appb-000015
2:建立三重debye-drude模型,采用三重debye-drude模型对所获取的血液层和血管层的复介电常数的实部值与虚部值分别进行拟合;拟合公式如下:
Figure PCTCN2016103033-appb-000016
3:确定在三重debye-drude模型中血液层和血管层需拟合的参数;对三重debye-drude模型进行有理式分解,分别计算实部(ε′)、虚部(ε″)对应的多项式,计算公式如下:
Figure PCTCN2016103033-appb-000017
Figure PCTCN2016103033-appb-000018
确定需要拟合的参数包括:ε=a、Δε1=b、τ1=c、Δε2=d、τ2=e、Δε3=g、τ3=h、σi=k;
4:在Origin软件中建立对应的非线性曲线y1、y2,
y1=ε′                (8)
y2=ε"               (9)
其中,
y1=a+b/(1+(2×3.1415926×f×c)^2)+d/(1+(2*3.1415926*f*e)^2)+
g/(1+(2×3.1415926×f×h)^2)                (10)
y2=(b×2×3.1415926×f×c)/(1+(2×3.1415926×f×c)^2)+(d×2×3.1415926×f×e)/(1+(2×3.1415926×f×e)^2)+
(g×2×3.1415926×f×h)/(1+(2×3.1415926×f×h)^2)+k/(2×3.1415926×f×8.85418×pow(10,-12))   (11)
5:采用Cole-Cole模型中的初始值分别对a、b、c、d、e、g、h、k参数赋迭代拟合的初始值,利用Origin软件进行参数拟合;
6:将血液层和血管层的参数拟合结果分别代入Debye-Drude三重极点模型中,然后利用Origin软件对血液层和血管层的参数拟合结果进行误差分析;
7:将血液层和血管层的参数拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算。
本发明实施例的建立血液电磁仿真模型的方法及装置在建模过程中,根据 血脂的浓度和血液电磁仿真模型中血液体积的大小,计算血液电磁仿真模型中血脂粒子的数目,通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型,并利用三重debye-drude模型对血液电磁仿真模型中不同组织层的电磁参数进行拟合,从而设定其电磁参数。通过本发明建立的血液电磁仿真模型可用于分析血脂与电磁波的相互作用机理,获取在不同血脂浓度下的电磁波响应特性,为无创血脂检测技术的发展提供重要的理论支撑。同时,本发明还具有使用成本低、仿真精度高等优点。
虽然本发明参照当前的较佳实施方式进行了描述,但本领域的技术人员应能理解,上述较佳实施方式仅用来说明本发明,并非用来限定本发明的保护范围,任何在本发明的精神和原则范围之内,所做的任何修饰、等效替换、改进等,均应包含在本发明的权利保护范围之内。

Claims (10)

  1. 一种建立血液电磁仿真模型的方法,其特征在于,包括:
    步骤a:建立血液电磁仿真模型;
    步骤b:根据血脂的浓度和血液电磁仿真模型中血液的体积,计算血液电磁仿真模型中血脂粒子的数目;
    步骤c:根据计算结果将血脂粒子随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型。
  2. 根据权利要求1所述的建立血液电磁仿真模型的方法,其特征在于,所述步骤a前还包括:确定血液电磁仿真模型的整体结构;所述血液电磁仿真模型的整体结构为圆柱体,所述血液电磁仿真模型包括血管层、血液层和血脂粒子层,所述血管层、血液层和血脂粒子层的分布位置分别为:血管层位于最外层,血管层的长度为h,血管层的内径为d,外径为D,血管层的厚度为r12=(D-d)/2;血液层位于血管层中,血液层的半径为r=d/2;血脂粒子层分布在血液层中。
  3. 根据权利要求2所述的建立血液电磁仿真模型的方法,其特征在于,在所述步骤b中,所述血液电磁仿真模型中血脂粒子数目的计算公式为:
    Figure PCTCN2016103033-appb-100001
    上述公式中,n为血脂粒子的数目,N为中性脂肪分子和类脂分子的数目,ρ为血脂浓度,V为血液体积,M=ρ×V/1000,NA=6.02×1023,V=1000×π(d/2)2×h。
  4. 根据权利要求3所述的建立血液电磁仿真模型的方法,其特征在于,在所述步骤c中,所述建立血脂浓度可变的血液电磁仿真模型具体包括:
    步骤c1:生成n个在(-1,1)间均匀分布的随机数
    Figure PCTCN2016103033-appb-100002
    步骤c2:依据概率理论的中心极限定理,生成一个服从正态分布N(μ,σ)的随机值,生成随机值的公式为:
    Figure PCTCN2016103033-appb-100003
    在上述公式中,
    Figure PCTCN2016103033-appb-100004
    为均匀分布随机数,μ是正态分布随机数的期望值,σ是正态分布随机数的均方差,n是产生正态分布随机数所需的均匀分布随机数的个数;
    步骤c3:根据上述生成随机值的公式确定在血液电磁仿真模型中每个血脂粒子的位置,建立血脂浓度可变的血液电磁仿真模型。
  5. 根据权利要求4所述的建立血液电磁仿真模型的方法,其特征在于,所述步骤c后还包括:利用三重debye-drude模型对血液电磁仿真模型中血液层和血管层的电磁参数进行拟合,并将拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算。
  6. 一种建立血液电磁仿真模型的装置,其特征在于,包括:
    第一模型建立模块:用于建立血液电磁仿真模型;
    血脂粒子数目计算模块:用于根据血脂的浓度和血液电磁仿真模型中血液的体积,计算血液电磁仿真模型中血脂粒子的数目;
    第二模型建立模块:用于根据计算结果将血脂粒子随机分布在血液电磁仿真模型中,并通过控制血脂粒子的数目,建立血脂浓度可变的血液电磁仿真模型。
  7. 根据权利要求6所述的建立血液电磁仿真模型的装置,其特征在于,还包括结构计算模块,所述结构计算模块用于确定血液电磁仿真模型的整体结构;所述血液电磁仿真模型的整体结构为圆柱体,所述血液电磁仿真模型包括血管层、血液层和血脂粒子层,所述血管层、血液层和血脂粒子层的分布位置分别 为:血管层位于最外层,血管层的长度为h,血管层的内径为d,外径为D,血管层的厚度为r12=(D-d)/2;血液层位于血管层中,血液层的半径为r=d/2;血脂粒子层分布在血液层中。
  8. 根据权利要求7所述的建立血液电磁仿真模型的装置,其特征在于,所述血脂粒子数目计算模块计算血液电磁仿真模型中血脂粒子数目的公式为:
    Figure PCTCN2016103033-appb-100005
    上述公式中,n为血脂粒子的数目,N为中性脂肪分子和类脂分子的数目,ρ为血脂浓度,V为血液体积,M=ρ×V/1000,NA=6.02×1023,V=1000×π(d/2)2×h。
  9. 根据权利要求8所述的建立血液电磁仿真模型的装置,其特征在于,所述第二模型建立模块建立血脂浓度可变的血液电磁仿真模型的方式包括:生成n个在(-1,1)间均匀分布的随机数
    Figure PCTCN2016103033-appb-100006
    依据概率理论的中心极限定理,生成一个服从正态分布N(μ,σ)的随机值,生成随机值的公式为:
    Figure PCTCN2016103033-appb-100007
    根据上述生成随机值的公式确定在血液电磁仿真模型中每个血脂粒子的位置,建立血脂浓度可变的血液电磁仿真模型;在上述公式中,
    Figure PCTCN2016103033-appb-100008
    为均匀分布随机数,μ是正态分布随机数的期望值,σ是正态分布随机数的均方差,n是产生正态分布随机数所需的均匀分布随机数的个数。
  10. 根据权利要求9所述的建立血液电磁仿真模型的装置,其特征在于,还包括参数计算模块,所述参数计算模块用于利用三重debye-drude模型对血液电磁仿真模型中血液层和血管层的电磁参数进行拟合,并将拟合结果导入血液电磁仿真模型中,对血液电磁仿真模型进行数值计算。
PCT/CN2016/103033 2016-09-28 2016-10-24 一种建立血液电磁仿真模型的方法及装置 WO2018058720A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610862038.9A CN106503302B (zh) 2016-09-28 2016-09-28 一种建立血液电磁仿真模型的方法及装置
CN201610862038.9 2016-09-28

Publications (1)

Publication Number Publication Date
WO2018058720A1 true WO2018058720A1 (zh) 2018-04-05

Family

ID=58290050

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/103033 WO2018058720A1 (zh) 2016-09-28 2016-10-24 一种建立血液电磁仿真模型的方法及装置

Country Status (2)

Country Link
CN (1) CN106503302B (zh)
WO (1) WO2018058720A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113536626A (zh) * 2021-06-25 2021-10-22 北京航空航天大学 基于Cole-Cole模型的DGTD电磁瞬态仿真方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108877445A (zh) * 2018-07-19 2018-11-23 天津大学 一种基于dla分形重构耳垂模型中血液分布的方法
CN110729050A (zh) * 2019-09-01 2020-01-24 天津大学 一种用于血糖检测的三维耳垂模型的建立方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102525443A (zh) * 2010-09-16 2012-07-04 西门子公司 非侵入性冠状动脉病评估的方法和系统
CN104104450A (zh) * 2014-06-20 2014-10-15 中国科学院深圳先进技术研究院 基于非均匀介质的人体通信信道建模方法和系统
US20150161297A1 (en) * 2013-12-05 2015-06-11 Fujitsu Limited Apparatus and method for generating shape data
CN104720894A (zh) * 2015-02-11 2015-06-24 中山大学附属第一医院 一种血管手术方式的合理性分析方法
US20160180055A1 (en) * 2014-03-31 2016-06-23 Heartflow, Inc. Systems and methods for determining blood flow characteristics using flow ratio

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8380541B1 (en) * 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
CN105205211B (zh) * 2015-08-20 2018-06-19 电子科技大学 表面通道型混频肖特基二极管三维电磁仿真模型建模方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102525443A (zh) * 2010-09-16 2012-07-04 西门子公司 非侵入性冠状动脉病评估的方法和系统
US20150161297A1 (en) * 2013-12-05 2015-06-11 Fujitsu Limited Apparatus and method for generating shape data
US20160180055A1 (en) * 2014-03-31 2016-06-23 Heartflow, Inc. Systems and methods for determining blood flow characteristics using flow ratio
CN104104450A (zh) * 2014-06-20 2014-10-15 中国科学院深圳先进技术研究院 基于非均匀介质的人体通信信道建模方法和系统
CN104720894A (zh) * 2015-02-11 2015-06-24 中山大学附属第一医院 一种血管手术方式的合理性分析方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113536626A (zh) * 2021-06-25 2021-10-22 北京航空航天大学 基于Cole-Cole模型的DGTD电磁瞬态仿真方法
CN113536626B (zh) * 2021-06-25 2023-05-26 北京航空航天大学 基于Cole-Cole模型的DGTD电磁瞬态仿真方法

Also Published As

Publication number Publication date
CN106503302A (zh) 2017-03-15
CN106503302B (zh) 2019-08-23

Similar Documents

Publication Publication Date Title
Martin et al. A post-processing method for three-dimensional electrical impedance tomography
WO2018058720A1 (zh) 一种建立血液电磁仿真模型的方法及装置
Avanaki et al. Two applications of solid phantoms in performance assessment of optical coherence tomography systems
Sforza et al. Blood-flow characteristics in a terminal basilar tip aneurysm prior to its fatal rupture
Martelli et al. Phantoms for diffuse optical imaging based on totally absorbing objects, part 1: Basic concepts
Li et al. Unveiling the development of intracranial injury using dynamic brain EIT: an evaluation of current reconstruction algorithms
Miki et al. Patient-specific modelling of pulmonary airflow using GPU cluster for the application in medical practice
Hartinger et al. Monte Carlo modeling of angiographic optical coherence tomography
Chen et al. Development of a portable electrical impedance tomography device for online thrombus detection in extracorporeal-circulation equipment
Li et al. Application of virtual reality based on 3D-CTA in intracranial aneurysm surgery
Molina et al. The effect of arabinoxylan and wheat bran incorporation on dough rheology and thermal processing of rotary-moulded biscuits
Fishler et al. A microfluidic model of biomimetically breathing pulmonary acinar airways
CN104897449B (zh) 一种人体组织介电特性模拟材料的配置方法
Jain et al. Full wave modeling of brain waves as electromagnetic waves
Turoń-Skrzypińska et al. Does exercising with the use of virtual reality during haemodialysis have an impact on plasma levels of interleukin 1β, interleukin 6, and interleukin 8?
WO2018058719A1 (zh) 一种血脂检测建模方法及装置
Singh et al. New method for calculation of average electric properties of reference head phantom in microwave imaging
Zhu et al. Adaptive optimization on ultrasonic transmission tomography-based temperature image for biomedical treatment
Costanzo et al. Tissue-mimicking phantoms: Dielectric characterization and design of a multi-layer substrate for microwave blood glucose monitoring
Li et al. Research on an anthropomorphic phantom for evaluation of the medical device electromagnetic field exposure SAR
CN107526936A (zh) 肝灌注的定量测试方法
Frangi et al. Special Issue on Multiscale Modeling and Analysis in Computational Biology and Medicine—Part-1
Paz et al. Finite element analysis to predict temperature distribution in the human neck with abnormal thyroid: A proof of concept
Wang et al. MRI-aided tissues interface characterization: An accurate signal propagation time calculation method for UWB breast tumor imaging
Manohar " In Gello" Imaging

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16917467

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 25.07.2019)

122 Ep: pct application non-entry in european phase

Ref document number: 16917467

Country of ref document: EP

Kind code of ref document: A1